PKC and MAPK signalling pathways regulate vascular endothelin receptor expression

European Journal of Pharmacology

Volumn 580, Issue 1-2, 2008, Pages 190-200

  Nilsson, David ^a   Wackenfors, Angelica ^a   Gustafsson, Lotta ^a   Ugander, Martin ^a   Ingemansson, Richard ^a   Edvinsson, Lars ^a   Malmsjö, Malin ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Contraction; Coronary artery; Endothelin; Vascular

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 3 [8 [(DIMETHYLAMINO)METHYL] 6,7,8,9 TETRAHYDROPYRIDO[1,2 A]INDOL 10 YL] 4 (1 METHYL 1H INDOL 3 YL) 1H PYRROLE 2,5 DIONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BISINDOLYLMALEIMIDE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C; SARAFOTOXIN S6C;

ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR DISEASE; CELL CULTURE; CONTROLLED STUDY; CORONARY ARTERY; IMMUNOFLUORESCENCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SWINE;

ANIMALS; CARDIOVASCULAR DISEASES; CORONARY VESSELS; ENDOTHELIN-1; FEMALE; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; ORGAN CULTURE TECHNIQUES; PROTEIN KINASE C; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; RNA, MESSENGER; SIGNAL TRANSDUCTION; SWINE; UP-REGULATION; VIPER VENOMS;

EID: 37649008331     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.10.071     Document Type: Article

References (45)

1. Adner M., Cantera L., Ehlert F., Nilsson L., and Edvinsson L. Plasticity of contractile endothelin-B receptors in human arteries after organ culture. Br. J. Pharmacol. 119 (1996) 1159-1166
2. Alm R., Edvinsson L., and Malmsjo M. Organ culture: a new model for vascular endothelium dysfunction. BMC Cardiovasc. Dis. 2 (2002) 8
3. Aoki H., Richmond M., Izumo S., and Sadoshima J. Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro. Biochem. J. 347 Pt 1 (2000) 275-284
4. Arai H., Hori S., Aramori I., Ohkubo H., and Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348 (1990) 730-732
5. Beg S.A., Hansen-Schwartz J.A., Vikman P.J., Xu C.B., and Edvinsson L.I. ERK1/2 inhibition attenuates cerebral blood flow reduction and abolishes ET(B) and 5-HT(1B) receptor upregulation after subarachnoid hemorrhage in rat. J. Cereb. Blood Flow Metab. 26 (2006) 846-856
6. Beg S.S., Hansen-Schwartz J.A., Vikman P.J., Xu C.B., and Edvinsson L.I. Protein kinase C inhibition prevents upregulation of vascular ET(B) and 5-HT(1B) receptors and reverses cerebral blood flow reduction after subarachnoid haemorrhage in rats. J. Cereb. Blood Flow Metab. 27 (2007) 21-32
7. Bennett B.L., Sasaki D.T., Murray B.W., O'Leary E.C., Sakata S.T., Xu W., Leisten J.C., Motiwala A., Pierce S., Satoh Y., Bhagwat S.S., Manning A.M., and Anderson D.W. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 13681-13686
8. Cannan C.R., Burnett Jr. J.C., and Lerman A. Enhanced coronary vasoconstriction to endothelin-B-receptor activation in experimental congestive heart failure. Circulation 93 (1996) 646-651
9. Dagassan P.H., Breu V., Clozel M., Kunzli A., Vogt P., Turina M., Kiowski W., and Clozel J.P. Up-regulation of endothelin-B receptors in atherosclerotic human coronary arteries. J. Cardiovasc. Pharmacol. 27 (1996) 147-153
10. de Meyer G.H. AG: nitric oxide and vascular endothelium dysfunction. Nitric oxide; biology and pathobiology. Nitric oxide and Vascular endothelium dysfunction (2000) 547-568 2000
11. Ferrandi C., Ballerio R., Gaillard P., Giachetti C., Carboni S., Vitte P.A., Gotteland J.P., and Cirillo R. Inhibition of c-Jun N-terminal kinase decreases cardiomyocyte apoptosis and infarct size after myocardial ischemia and reperfusion in anaesthetized rats. Br. J. Pharmacol. 142 (2004) 953-960
12. Force T., Kuida K., Namchuk M., Parang K., and Kyriakis J.M. Inhibitors of protein kinase signaling pathways: emerging therapies for cardiovascular disease. Circulation 109 (2004) 1196-1205
13. Hansen-Schwartz J. Receptor changes in cerebral arteries after subarachnoid haemorrhage. Acta Neurol. Scand. 109 (2004) 33-44
14. Hansen-Schwartz J., Svensson C.L., Xu C.B., and Edvinsson L. Protein kinase mediated upregulation of endothelin A, endothelin B and 5-hydroxytryptamine 1B/1D receptors during organ culture in rat basilar artery. Br. J. Pharmacol. 137 (2002) 118-126
15. Hazzalin C.A., and Mahadevan L.C. MAPK-regulated transcription: a continuously variable gene switch?. Nat. Rev. Mol. Cell Biol. 3 (2002) 30-40
16. Henriksson M., Stenman E., and Edvinsson L. Intracellular pathways involved in upregulation of vascular endothelin type B receptors in cerebral arteries of the rat. Stroke 34 (2003) 1479-1483
17. Henriksson M., Stenman E., Vikman P., and Edvinsson L. Protein kinase C inhibition attenuates vascular ETB receptor upregulation and decreases brain damage after cerebral ischemia in rat. BMC Neurosci. 8 (2007) 7
18. Henriksson M., Vikman P., Stenman E., Beg S., and Edvinsson L. Inhibition of PKC activity blocks the increase of ETB receptor expression in cerebral arteries. BMC Pharmacol. 6 (2006) 13
19. Henriksson M., Xu C.B., and Edvinsson L. Importance of ERK1/2 in upregulation of endothelin type B receptors in cerebral arteries. Br. J. Pharmacol. 142 (2004) 1155-1161
20. Högestätt E.D., Andersson K.E., and Edvinsson L. Mechanical properties of rat cerebral arteries as studied by a sensitive device for recording of mechanical activity in isolated small blood vessels. Acta Physiol. Scand. 117 (1983) 49-61
21. Kaminska B. MAPK signalling pathways as molecular targets for anti-inflammatory therapy - from molecular mechanisms to therapeutic benefits. Biochim. Biophys. Acta 1754 (2005) 253-262
22. Komai N., Morishita R., Yamada S., Oishi M., Iguchi S., Aoki M., Sasaki M., Sakurabayashi I., Higaki J., and Ogihara T. Mitogenic activity of oxidized lipoprotein (a) on human vascular smooth muscle cells. Hypertension 40 (2002) 310-314
23. Lind H., Adner M., Erlinge D., Brunkwall J., and Edvinsson L. Selective increase of the contractile response to endothelin-1 in subcutaneous arteries from patients with essential hypertension. Blood Press. 8 (1999) 9-15
24. Liu B., Fisher M., and Groves P. Down-regulation of the ERK1 and ERK2 mitogen-activated protein kinases using antisense oligonucleotides inhibits intimal hyperplasia in a porcine model of coronary balloon angioplasty. Cardiovasc. Res. 54 (2002) 640-648
25. Lodge N.J., Zhang R., Halaka N.N., and Moreland S. Functional role of endothelin ETA and ETB receptors in venous and arterial smooth muscle. Eur. J. Pharmacol. 287 (1995) 279-285
26. Maguire J.J., and Davenport A.P. ETA receptor-mediated constrictor responses to endothelin peptides in human blood vessels in vitro. Br. J. Pharmacol. 115 (1995) 191-197
27. Murphy S., and Frishman W.H. Protein kinase C in cardiac disease and as a potential therapeutic target. Cardiol. Rev. 13 (2005) 3-12
28. Nilsson, D., Wackenfors, A., Gustafsson, L., Paulsson, P., Ingemansson, R., Edvinsson, L., Malmsjö, M., in press. Endothelin receptor mediated vasodilatation: effects of organ culture. Eur. J. Pharmacol. (3 Oct 2007).
29. Nishimoto S., and Nishida E. MAPK signalling: ERK5 versus ERK1/2. EMBO Rep. 7 (2006) 782-786
30. Saetrum Opgaard O., and Edvinsson L. Mechanical properties and effects of sympathetic co-transmitters on human coronary arteries and veins. Basic Res. Cardiol. 92 (1997) 168-180
31. Sakurai T., Yanagisawa M., Takuwa Y., Miyazaki H., Kimura S., Goto K., and Masaki T. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348 (1990) 732-735
32. Salamanca D.A., and Khalil R.A. Protein kinase C isoforms as specific targets for modulation of vascular smooth muscle function in hypertension. Biochem. Pharmacol. 70 (2005) 1537-1547
33. Schonwasser D.C., Marais R.M., Marshall C.J., and Parker P.J. Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes. Mol. Cell Biol. 18 (1998) 790-798
34. Stenman E., Malmsjo M., Uddman E., Gido G., Wieloch T., and Edvinsson L. Cerebral ischemia upregulates vascular endothelin ET(B) receptors in rat. Stroke 33 (2002) 2311-2316
35. Szok D., Hansen-Schwartz J., and Edvinsson L. In depth pharmacological characterization of endothelin B receptors in the rat middle cerebral artery. Neurosci. Lett. 314 (2001) 69-72
36. Toullec D., Pianetti P., Coste H., Bellevergue P., Grand-Perret T., Ajakane M., Baudet V., Boissin P., Boursier E., Loriolle F., et al. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 266 (1991) 15771-15781
37. Uddman E., Adner M., and Edvinsson L. Protein kinase C inhibitors decrease endothelin ET(B) receptor mRNA expression and contraction during organ culture of rat mesenteric artery. Eur. J. Pharmacol. 452 (2002) 215-222
38. Uddman E., Henriksson M., Eskesen K., and Edvinsson L. Role of mitogen-activated protein kinases in endothelin ETB receptor up-regulation after organ culture of rat mesenteric artery. Eur. J. Pharmacol. 482 (2003) 39-47
39. Wackenfors A., Emilson M., Ingemansson R., Edvinsson L., and Malmsjo M. Ischemic heart disease down-regulates angiotensin type 1 receptor mRNA in human coronary arteries. Eur. J. Pharmacol. 503 (2004) 147-153
40. Wackenfors A., Emilson M., Ingemansson R., Hortobagyi T., Szok D., Tajti J., Vecsei L., Edvinsson L., and Malmsjo M. Ischemic heart disease induces upregulation of endothelin receptor mRNA in human coronary arteries. Eur. J. Pharmacol. 484 (2004) 103-109
41. Wackenfors A., Ingemansson R., and Malmsjo M. Endothelin receptors in endothelium-denuded human coronary artery bypass grafts and coronary arteries. Ann. Thorac. Surg. 75 (2003) 874-881
42. Wenzel R.R., Duthiers N., Noll G., Bucher J., Kaufmann U., and Luscher T.F. Endothelin and calcium antagonists in the skin microcirculation of patients with coronary artery disease. Circulation 94 (1996) 316-322
43. White L.R., Leseth K.H., Moller S., Juul R., Adner M., Cappelen J., Bovim G., Aasly J., and Edvinsson L. Interleukin-1beta potentiates endothelin ET(B) receptor-mediated contraction in cultured segments of human temporal artery. Regul. Pept. 81 (1999) 89-95
44. Wilkinson S.E., Parker P.J., and Nixon J.S. Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C. Biochem. J. 294 Pt 2 (1993) 335-337
45. Vogel V., Bokemeyer D., Heller J., and Kramer H.J. Cardiac hypertrophy in the Prague-hypertensive rat is associated with enhanced JNK2 but not ERK tissue activity. Kidney Blood Press Res. 24 (2001) 52-56